The prevalence of SARS-CoV-2 infection and other public health outcomes during the BA.2/BA.2.12.1 surge, New York City, April-May 2022.
Saba A QasmiehMcKaylee M RobertsonChloe A TeasdaleSarah G KulkarniHeidi E JonesDavid A LarsenJohn J DennehyMargaret McNairyLuisa N BorrellDenis NashPublished in: Communications medicine (2023)
Our findings suggest that the true magnitude of NYC's BA.2/BA.2.12.1 surge may have been vastly underestimated by routine case counts and wastewater surveillance. Hybrid immunity, bolstered by the recent BA.1 surge, likely limited the severity of the BA.2/BA.2.12.1 surge.